(Q35653982)

9 August 2017

title

In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens (English)

1 reference

9 August 2017

0 references

Liebowitz LD

1

1 reference

9 August 2017

Saunders J

2

1 reference

9 August 2017

Fehler G

3

1 reference

9 August 2017

Ballard RC

4

1 reference

9 August 2017

Koornhof HJ

5

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 December 1986

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

9 August 2017

volume

30

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

948-950

1 reference

Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

The activity of ciprofloxacin and other 4-quinolones againstChlamydia trachomatis andMycoplasmas in vitro

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

Treatment of Penicillin-ResistantNeisseria gonorrhoeaewith Oral Norfloxacin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

Mycoplasmas of various hosts and their antibiotic sensitivities.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

Modifications of the growth inhibition test and its application to human T-mycoplasmas

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

Differentiation of fluorinated quinolone antibacterials with Neisseria gonorrhoeae isolates.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

Activities of new quinoline derivatives against genital pathogens

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

Antichlamydial activity of quinolone carboxylic acids

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

In vitro evaluation of A-56619 and A-56620, two new quinolones

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

Single dose ciprofloxacin for treating gonococcal infections in men.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

The antimicrobial susceptibility of Chlamydia trachomatis in cell culture

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180627

Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agents

12 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3101590

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vitro activity of norfloxacin againstMycoplasma hominis andUreaplasma urealyticum

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3101590

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.30.6.948

1 reference

9 August 2017

1 reference

9 August 2017

1 reference